ARDX
Ardelyx Inc
Price:  
6.19 
USD
Volume:  
2,895,875.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Ardelyx EV/EBITDA

-140.0%
Upside

As of 2025-09-18, the EV/EBITDA ratio of Ardelyx Inc (ARDX) is -44.11. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Ardelyx's latest enterprise value is 1,602.62 mil USD. Ardelyx's TTM EBITDA according to its financial statements is -36.33 mil USD. Dividing these 2 quantities gives us the above Ardelyx EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 8.4x - 13.6x 11.0x
Forward P/E multiples 12.3x - 19.2x 15.8x
Fair Price (2.31) - (2.51) (2.48)
Upside -137.4% - -140.6% -140.0%
6.19 USD
Stock Price
(2.48) USD
Fair Price

Ardelyx EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-09-16 -45.63
2025-09-15 -46.36
2025-09-12 -46.89
2025-09-11 -47.36
2025-09-10 -47.09
2025-09-09 -46.56
2025-09-08 -46.76
2025-09-05 -46.30
2025-09-04 -46.63
2025-09-03 -46.23
2025-09-02 -45.50
2025-08-29 -45.24
2025-08-28 -45.37
2025-08-27 -44.11
2025-08-26 -44.17
2025-08-25 -43.25
2025-08-22 -43.58
2025-08-21 -43.58
2025-08-20 -42.78
2025-08-19 -41.92
2025-08-18 -41.59
2025-08-15 -42.65
2025-08-14 -41.79
2025-08-13 -41.19
2025-08-12 -40.19
2025-08-11 -38.87
2025-08-08 -37.61
2025-08-07 -37.14
2025-08-06 -37.54
2025-08-05 -37.08
2025-08-04 -32.17
2025-08-01 -31.77
2025-07-31 -31.17
2025-07-30 -31.84
2025-07-29 -31.04
2025-07-28 -31.44
2025-07-25 -31.51
2025-07-24 -31.97
2025-07-23 -32.17
2025-07-22 -32.40
2025-07-21 -32.37
2025-07-18 -32.30
2025-07-17 -33.03
2025-07-16 -33.56
2025-07-15 -32.90
2025-07-14 -33.63
2025-07-11 -32.83
2025-07-10 -34.23
2025-07-09 -33.56
2025-07-08 -32.77